and sh‐C/EBPβ treatment enhanced the reduced MMP‐2 levels, whereas C/EBPβ overexpression increased MMP‐2 expression and activity by up‐regulating ACE2 expression, thus increasing the degradation of the ECM in mice with DCM. This evidence concerns the gene MMP2 and familial dilated cardiomyopathy.